Neurostimulation is a medical treatment that uses electrical impulses to change how nerves behave. Small devices deliver controlled pulses to specific parts of the nervous system, either calming overactive nerve signals or boosting underactive ones. It’s used to treat a surprisingly wide range of conditions, from Parkinson’s disease and chronic pain to depression and bladder dysfunction, typically after other treatments have failed.
How Electrical Pulses Change Nerve Activity
Your nervous system runs on electrical signals. Neurons fire in patterns, and when those patterns go wrong, you get symptoms: uncontrolled tremors, seizures, chronic pain, or persistent low mood. Neurostimulation works by introducing external electrical pulses that reshape those firing patterns.
The effects depend on the frequency of stimulation. Low-frequency pulses (around 1 Hz) pace neural networks into a steady, synchronized rhythm. This creates long-lasting periods of calm between nerve firings, essentially setting up protective windows that block abnormal high-frequency signals from breaking through. High-frequency pulses work differently. They can exhaust the chemical messengers neurons use to communicate, temporarily depleting them so runaway signals (like those in a seizure) lose steam. High-frequency stimulation can also cause a “depolarization block,” where nerve fibers become so electrically saturated they stop transmitting altogether, disconnecting a malfunctioning brain region from the rest of the network.
These aren’t permanent changes to the brain’s wiring. The effects persist while the device is active and, in some cases, for a period after stimulation stops due to the nervous system settling into the new rhythm.
Implanted Devices: DBS, VNS, and Spinal Cord Stimulators
Invasive neurostimulation involves surgically placing electrodes inside the body, connected to a small pulse generator typically implanted under the skin near the collarbone or abdomen. The three most established types target very different parts of the nervous system.
Deep Brain Stimulation
Deep brain stimulation (DBS) places thin electrodes directly into specific brain structures. The FDA first approved it in 1997 for essential tremor, the condition that causes involuntary shaking, especially in the hands. Since then, approvals have expanded to include Parkinson’s disease (2002), dystonia (2003), obsessive-compulsive disorder (2009), and epilepsy. Different conditions require targeting different brain regions. Parkinson’s tremor and rigidity respond to stimulation in the subthalamic nucleus or a structure called the globus pallidus, while essential tremor is treated by targeting part of the thalamus. Researchers are also investigating DBS for chronic pain and additional psychiatric conditions.
Vagus Nerve Stimulation
Vagus nerve stimulation (VNS) wraps an electrode around the vagus nerve in the neck, a major nerve that connects the brain to the heart, lungs, and digestive system. It’s approved for epilepsy and treatment-resistant depression. For epilepsy, only a small number of patients become completely seizure-free, but many experience meaningful improvement in quality of life when VNS is added to their medication. For depression, pilot studies have shown strong response rates, though the benefit builds gradually over weeks to months rather than appearing immediately.
Spinal Cord Stimulation
Spinal cord stimulation (SCS) places electrodes along the spinal cord to intercept pain signals before they reach the brain. It’s most commonly used for chronic back and leg pain, particularly after failed back surgery, as well as complex regional pain syndrome and pain from diabetic neuropathy. Success rates vary depending on the technology used. Conventional SCS delivers roughly 50% of patients a meaningful result, defined as at least a 50% reduction in pain. Newer high-frequency systems have pushed that number closer to 80% for both back and leg pain in clinical trials.
Non-Invasive Options: TMS and tDCS
Not all neurostimulation requires surgery. Two widely used non-invasive techniques work through the skull without any implants.
Transcranial magnetic stimulation (TMS) uses a magnetic coil held against the scalp to generate electrical currents in targeted brain areas. The FDA cleared it for major depression in 2008. A typical treatment course involves five sessions per week for four to six weeks, with each session delivering thousands of magnetic pulses. In clinical practice, about 39% of patients in one study reached remission, with better outcomes among those whose depression was mild to moderate rather than severe. TMS is also being studied for anxiety, PTSD, and substance use disorders.
Transcranial direct current stimulation (tDCS) takes a simpler approach, sending a weak constant electrical current between two electrodes placed on the scalp. It doesn’t require the specialized equipment of TMS and is being researched for depression, cravings in substance use disorders, and cognitive enhancement. Both TMS and tDCS typically target the dorsolateral prefrontal cortex, a brain region involved in decision-making, impulse control, and mood regulation.
Sacral Nerve Stimulation for Bladder and Bowel Problems
Neurostimulation isn’t limited to the brain and spine. Sacral nerve stimulation (SNS) targets nerves at the base of the spine that control bladder and bowel function. It’s used for people with urge incontinence, overactive bladder, and urinary retention that hasn’t responded to other treatments.
Clinical results have been consistently strong. In one study of 23 implanted patients, 83% achieved at least 50% improvement in their primary symptom, with 61% reaching 90% improvement or better. In patients with urinary retention, the amount of urine left in the bladder after voiding dropped from 78% of total output to just 10%. Patients with frequency and urgency saw their daily voiding episodes drop from 16 to 9, and leaking episodes fell from roughly 6.5 to 2 per day.
Open-Loop vs. Closed-Loop Systems
Most neurostimulation devices today are “open-loop,” meaning they deliver a fixed pattern of stimulation based on pre-programmed settings regardless of what’s happening in your body at any given moment. If your symptoms fluctuate throughout the day, the device doesn’t adjust.
Closed-loop systems represent a newer approach. These devices continuously monitor physiological signals, such as brain wave patterns, and automatically adjust stimulation in real time based on what they detect. If the system senses the electrical signature of an approaching seizure, for example, it can ramp up stimulation to prevent it, then dial back when things stabilize. This makes treatment more precise, potentially more effective, and more efficient with battery life since the device isn’t stimulating unnecessarily.
Who Qualifies for Implanted Neurostimulation
Implanted neurostimulation is generally reserved for people who haven’t responded adequately to less invasive treatments. For spinal cord stimulation, current guidelines recommend a trial period before permanent implantation. During the trial, temporary electrodes are placed and connected to an external generator for several days to a week. If the trial provides sufficient relief, a permanent device is implanted.
Psychological screening is a required part of the evaluation process. All candidates are assessed with validated questionnaires that screen for depression, anxiety, catastrophizing, and coping ability. Untreated substance use disorders and active psychosis are considered absolute contraindications because they’re associated with poor long-term outcomes. Patients also need to demonstrate a clear understanding of what the procedure involves, its risks, and the long-term maintenance the device requires, including periodic battery replacements and programming adjustments.
Risks and Hardware Complications
Non-invasive methods like TMS carry minimal risk, with scalp discomfort and mild headache being the most common side effects. Implanted devices carry more significant concerns, though life-threatening complications are rare for both surgical and minimally invasive implantation techniques.
The biggest issue with implanted systems is hardware failure, not biological complications. Lead migration, where the electrode shifts from its original position, is the most common problem, occurring in about 13% of spinal cord stimulator cases. Lead breakage follows at roughly 9%. When a lead migrates, the device can sometimes be reprogrammed to compensate. If reprogramming fails, surgical revision is the only fix, and nearly half of patients who need one revision will end up needing multiple procedures. Overall complication rates for spinal cord stimulators range from about 5% to 40% across studies, with most problems being mechanical rather than medical. Infection and blood collection at the implant site are possible but less frequent.